Home/All Molecules/Irbesartan

Irbesartan Range

Comprehensive Irbesartan portfolio for Franchise & Manufacturing.

Category
irbesartan
Total Formulations
8
Available Forms
Tablets

Expand Your Business with Our Multiple Divisions


Browse Irbesartan portfolio by Dosage Form


The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Irbesartan batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Irbesartan PCD Pharma Franchise Company

Irbesartan PCD Pharma Franchise Company

Cafoli Lifecare is a trusted Irbesartan PCD pharma franchise company offering 8 WHO-GMP certified Irbesartan formulations manufactured in DCGI-approved facilities. Our range is supplied to franchise partners across India with district-wise monopoly rights.

What is Irbesartan?

Irbesartan is an angiotensin II receptor blocker (ARB) that relaxes blood vessels by blocking the action of angiotensin II. It is used to treat hypertension and to protect the kidneys in type 2 diabetic nephropathy. Learn more on PubChem.

Available Irbesartan Formulations

Our Irbesartan portfolio spans 8 formulations across the following dosage forms: Tablets. As a prescription cardiovascular medicine, these are supplied against valid prescriptions.

Therapeutic Applications

Irbesartan is prescribed for hypertension and diabetic kidney disease. As a prescription cardiovascular medicine it is used under cardiologists, nephrologists, diabetologists and physicians.

Why Irbesartan is a High-Potential Molecule for Distributors

Hypertension is a lifelong condition, so ARBs like Irbesartan drive dependable monthly refills. Its renal-protective benefit in diabetic patients broadens the prescriber base and repeat demand for franchise partners.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers district-wise monopoly rights, WHO-GMP and DCGI-approved manufacturing, timely supply and complete promotional inputs. With 1000+ franchise partners, we back every associate marketing our Irbesartan range with reliable support.

References

  1. PubChem - Irbesartan
  2. PubMed - Irbesartan research

Aceclofenac in Modern Clinical Practice

Our formulations of Irbesartan find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:


FAQ about Irbesartan in PCD Franchise

Start Your Irbesartan Franchise with Cafoli Lifecare

Ready to build your Irbesartan PCD franchise? Call 9518447302 or email info@cafoli.in to secure district-wise monopoly rights today.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

Cafoli Lifecare offers 8 Irbesartan formulations across Tablets, giving franchise partners a complete portfolio.

We grant district-wise monopoly rights, so each partner markets our Irbesartan range exclusively in an assigned territory without internal competition.

Cardiologists, nephrologists, diabetologists and physicians prescribe Irbesartan for hypertension and diabetic kidney disease.

Irbesartan is proven to slow the progression of diabetic nephropathy, so it is widely prescribed for hypertensive patients with type 2 diabetes, supporting steady repeat demand.

You need a valid Drug License and GST registration. Our team then processes your monopoly agreement and dispatches promotional inputs.